CVS Current Deferred Revenue vs Capex To Revenue Analysis

CVS Stock

USD 59.85 0.11 0.18%

CVS Health financial indicator trend analysis is way more than just evaluating CVS Health Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CVS Health Corp is a good investment. Please check the relationship between CVS Health Current Deferred Revenue and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Current Deferred Revenue vs Capex To Revenue

Current Deferred Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CVS Health Corp Current Deferred Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between CVS Health's Current Deferred Revenue and Capex To Revenue is -0.61. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of CVS Health Corp, assuming nothing else is changed. The correlation between historical values of CVS Health's Current Deferred Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of CVS Health Corp are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Current Deferred Revenue i.e., CVS Health's Current Deferred Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.61

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from CVS Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CVS Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

At this time, CVS Health's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.21 in 2024, whereas Tax Provision is likely to drop slightly above 2 B in 2024.

	2021	2022	2023	2024 (projected)
Operating Income	13.2B	15.7B	13.7B	14.4B
Other Operating Expenses	277.1B	314.3B	601.0B	631.0B

Operating Income Other Operating Expenses

CVS Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will
Total Assets		0.98	0.78	0.98	0.97	0.94	0.97	0.91	0.87	1.0	0.93	0.93	0.94	0.44	0.98	0.88	0.9	-0.93	1.0	0.77	0.98	0.82	0.95	0.94	0.96	0.99
Short Long Term Debt Total	0.98		0.67	0.93	0.91	0.92	1.0	0.85	0.81	0.99	0.89	0.88	0.87	0.36	1.0	0.84	0.94	-0.96	0.99	0.74	0.93	0.84	0.97	0.87	0.97	0.98
Other Current Liab	0.78	0.67		0.88	0.8	0.79	0.64	0.83	0.85	0.75	0.78	0.85	0.89	0.3	0.66	0.68	0.53	-0.71	0.76	0.7	0.86	0.68	0.56	0.87	0.7	0.75
Total Current Liabilities	0.98	0.93	0.88		0.95	0.93	0.91	0.94	0.9	0.97	0.93	0.94	0.98	0.37	0.93	0.86	0.81	-0.93	0.97	0.8	0.99	0.82	0.87	0.97	0.93	0.97
Total Stockholder Equity	0.97	0.91	0.8	0.95		0.92	0.89	0.94	0.86	0.96	0.9	0.9	0.93	0.61	0.91	0.92	0.83	-0.82	0.94	0.75	0.97	0.78	0.9	0.94	0.89	0.96
Property Plant And Equipment Net	0.94	0.92	0.79	0.93	0.92		0.9	0.85	0.89	0.94	0.82	0.92	0.88	0.5	0.9	0.81	0.85	-0.85	0.93	0.76	0.93	0.87	0.82	0.89	0.9	0.9
Net Debt	0.97	1.0	0.64	0.91	0.89	0.9		0.83	0.76	0.98	0.88	0.84	0.85	0.35	0.99	0.83	0.94	-0.95	0.98	0.74	0.91	0.84	0.98	0.84	0.96	0.97
Retained Earnings	0.91	0.85	0.83	0.94	0.94	0.85	0.83		0.82	0.89	0.85	0.84	0.95	0.5	0.83	0.96	0.7	-0.8	0.89	0.74	0.96	0.8	0.82	0.99	0.78	0.92
Cash	0.87	0.81	0.85	0.9	0.86	0.89	0.76	0.82		0.85	0.74	0.99	0.85	0.44	0.81	0.76	0.74	-0.82	0.86	0.56	0.91	0.67	0.72	0.88	0.85	0.83
Non Current Assets Total	1.0	0.99	0.75	0.97	0.96	0.94	0.98	0.89	0.85		0.92	0.91	0.92	0.43	0.99	0.87	0.92	-0.94	1.0	0.76	0.96	0.83	0.96	0.91	0.97	0.99
Non Currrent Assets Other	0.93	0.89	0.78	0.93	0.9	0.82	0.88	0.85	0.74	0.92		0.82	0.95	0.28	0.89	0.75	0.75	-0.87	0.92	0.89	0.91	0.69	0.87	0.87	0.9	0.94
Cash And Short Term Investments	0.93	0.88	0.85	0.94	0.9	0.92	0.84	0.84	0.99	0.91	0.82		0.89	0.41	0.88	0.78	0.81	-0.88	0.92	0.63	0.94	0.72	0.8	0.9	0.92	0.89
Net Receivables	0.94	0.87	0.89	0.98	0.93	0.88	0.85	0.95	0.85	0.92	0.95	0.89		0.35	0.87	0.84	0.71	-0.87	0.93	0.84	0.98	0.74	0.82	0.97	0.87	0.94
Common Stock Shares Outstanding	0.44	0.36	0.3	0.37	0.61	0.5	0.35	0.5	0.44	0.43	0.28	0.41	0.35		0.37	0.63	0.39	-0.15	0.38	0.24	0.46	0.36	0.41	0.46	0.3	0.43
Non Current Liabilities Total	0.98	1.0	0.66	0.93	0.91	0.9	0.99	0.83	0.81	0.99	0.89	0.88	0.87	0.37		0.83	0.95	-0.95	0.99	0.72	0.92	0.8	0.98	0.86	0.97	0.98
Inventory	0.88	0.84	0.68	0.86	0.92	0.81	0.83	0.96	0.76	0.87	0.75	0.78	0.84	0.63	0.83		0.74	-0.74	0.86	0.62	0.91	0.77	0.85	0.92	0.74	0.89
Other Current Assets	0.9	0.94	0.53	0.81	0.83	0.85	0.94	0.7	0.74	0.92	0.75	0.81	0.71	0.39	0.95	0.74		-0.88	0.91	0.54	0.81	0.81	0.94	0.72	0.93	0.88
Other Stockholder Equity	-0.93	-0.96	-0.71	-0.93	-0.82	-0.85	-0.95	-0.8	-0.82	-0.94	-0.87	-0.88	-0.87	-0.15	-0.95	-0.74	-0.88		-0.96	-0.68	-0.9	-0.79	-0.9	-0.85	-0.96	-0.93
Total Liab	1.0	0.99	0.76	0.97	0.94	0.93	0.98	0.89	0.86	1.0	0.92	0.92	0.93	0.38	0.99	0.86	0.91	-0.96		0.77	0.97	0.83	0.95	0.92	0.97	0.99
Property Plant And Equipment Gross	0.77	0.74	0.7	0.8	0.75	0.76	0.74	0.74	0.56	0.76	0.89	0.63	0.84	0.24	0.72	0.62	0.54	-0.68	0.77		0.77	0.67	0.67	0.75	0.7	0.78
Total Current Assets	0.98	0.93	0.86	0.99	0.97	0.93	0.91	0.96	0.91	0.96	0.91	0.94	0.98	0.46	0.92	0.91	0.81	-0.9	0.97	0.77		0.8	0.88	0.98	0.91	0.97
Short Term Debt	0.82	0.84	0.68	0.82	0.78	0.87	0.84	0.8	0.67	0.83	0.69	0.72	0.74	0.36	0.8	0.77	0.81	-0.79	0.83	0.67	0.8		0.76	0.78	0.75	0.8
Intangible Assets	0.95	0.97	0.56	0.87	0.9	0.82	0.98	0.82	0.72	0.96	0.87	0.8	0.82	0.41	0.98	0.85	0.94	-0.9	0.95	0.67	0.88	0.76		0.81	0.93	0.96
Accounts Payable	0.94	0.87	0.87	0.97	0.94	0.89	0.84	0.99	0.88	0.91	0.87	0.9	0.97	0.46	0.86	0.92	0.72	-0.85	0.92	0.75	0.98	0.78	0.81		0.83	0.93
Common Stock	0.96	0.97	0.7	0.93	0.89	0.9	0.96	0.78	0.85	0.97	0.9	0.92	0.87	0.3	0.97	0.74	0.93	-0.96	0.97	0.7	0.91	0.75	0.93	0.83		0.95
Good Will	0.99	0.98	0.75	0.97	0.96	0.9	0.97	0.92	0.83	0.99	0.94	0.89	0.94	0.43	0.98	0.89	0.88	-0.93	0.99	0.78	0.97	0.8	0.96	0.93	0.95

Click cells to compare fundamentals

CVS Health Account Relationship Matchups

CVS Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	222.4B	230.7B	233.0B	228.3B	249.7B	262.2B
Short Long Term Debt Total	89.0B	85.0B	76.0B	70.7B	79.4B	83.4B
Other Current Liab	4.8B	43.8B	49.4B	51.1B	59.6B	62.6B
Total Current Liabilities	53.3B	62.0B	67.8B	69.7B	79.2B	83.1B
Total Stockholder Equity	63.9B	69.4B	75.1B	71.0B	76.5B	80.3B
Property Plant And Equipment Net	32.9B	33.3B	32.0B	30.7B	30.4B	32.0B
Net Debt	83.3B	77.2B	66.6B	57.8B	71.2B	74.7B
Retained Earnings	45.1B	49.6B	54.9B	56.1B	61.6B	64.7B
Cash	5.7B	7.9B	9.4B	12.9B	8.2B	8.6B
Non Current Assets Total	172.1B	174.3B	173.0B	162.6B	181.9B	191.0B
Non Currrent Assets Other	4.6B	4.6B	4.7B	4.0B	7.9B	8.3B
Cash And Short Term Investments	8.1B	10.9B	12.5B	15.7B	11.5B	12.0B
Net Receivables	19.6B	21.7B	24.4B	27.3B	35.2B	37.0B
Common Stock Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B	984.2M
Liabilities And Stockholders Equity	222.4B	230.7B	233.0B	228.3B	249.7B	262.2B
Non Current Liabilities Total	105.0B	99.0B	89.8B	87.2B	93.9B	98.6B
Inventory	17.5B	18.5B	17.8B	19.1B	18.0B	18.9B
Other Current Assets	5.1B	5.3B	5.3B	3.5B	3.2B	3.3B
Other Stockholder Equity	(28.2B)	(28.2B)	(28.2B)	(31.9B)	(33.8B)	(32.1B)
Total Liab	158.3B	161.0B	157.6B	157.0B	173.1B	181.7B
Property Plant And Equipment Gross	32.9B	33.3B	12.9B	12.9B	51.1B	53.7B
Total Current Assets	50.3B	56.4B	60.0B	65.7B	67.9B	71.3B
Accumulated Other Comprehensive Income	1.0B	1.4B	965M	(1.5B)	(297M)	(311.9M)
Short Term Debt	5.4B	7.1B	5.9B	3.5B	4.6B	4.9B
Intangible Assets	33.1B	31.1B	29.0B	24.8B	29.2B	30.7B
Accounts Payable	10.5B	11.1B	12.5B	14.8B	14.9B	15.6B
Common Stock	46.0B	46.5B	47.4B	48.2B	49.0B	51.4B
Good Will	79.7B	79.6B	79.1B	78.2B	91.3B	95.8B
Common Stock Total Equity	46.0B	46.5B	47.4B	48.2B	55.4B	58.2B
Other Liab	21.4B	21.0B	19.7B	19.9B	22.9B	24.1B
Other Assets	9.1B	51.0B	9.8B	7.6B	8.7B	4.8B
Long Term Debt	64.7B	59.2B	52.0B	50.5B	58.6B	61.6B
Treasury Stock	(28.2B)	(28.2B)	(28.2B)	(31.9B)	(28.7B)	(27.2B)
Property Plant Equipment	32.9B	12.6B	12.9B	12.9B	14.8B	9.5B
Current Deferred Revenue	32.6B	38.0B	43.8B	3.9B	57.1B	60.0B
Short Term Investments	2.4B	3B	3.1B	2.8B	3.3B	3.4B
Net Tangible Assets	(49.0B)	(41.3B)	(33.1B)	71.0B	63.9B	67.1B
Noncontrolling Interest In Consolidated Entity	318M	306M	312M	300M	345M	362.3M
Retained Earnings Total Equity	45.1B	49.6B	54.9B	56.1B	64.6B	39.9B
Long Term Debt Total	64.7B	59.2B	52.0B	50.5B	58.0B	34.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC